Diseases, Conditions, Syndromes

Monoclonal antibody prevents malaria in small NIH trial

One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite. The small, carefully monitored ...

Diseases, Conditions, Syndromes

WHO mass-testing three potential COVID-19 treatments

The World Health Organization on Wednesday announced major international trials of three drugs to find out whether they improve the condition of hospitalised COVID-19 patients.

Diseases, Conditions, Syndromes

New insights into immune responses to malaria

Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically.

page 18 from 40